FindTrial
Sign In

Application of flash glucose monitoring to evaluate the effect of blood glucose changes on prognosis in patients with novel coronavirus pneumonia (COVID-19)

Application of flash glucose monitoring to evaluate the effect of hyperglycemia and glycemic variability on prognosis in patients with novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030436
Enrollment
Unknown
Registered
2020-03-01
Start date
2020-03-06
Completion date
Unknown
Last updated
2020-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patient with novel coronavirus pneumonia (including nucleic acid positive case or clinically diagnosed case); 2. patients with type 2 diabetes; 3. Aged between 18-80 years old; 4. With effective flash glucose monitoring data.

Exclusion criteria

Exclusion criteria: 1.diabetic ketoacidosis, hyperosmolar hyperglycemic status, or severe recurrent hypoglycemia occurred within 3 months; 2.previous history of cardiovascular disease, malignant tumor, mental illness or severe liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
time in range;—

Countries

China

Contacts

Public ContactZHOU JIAN

Shanghai Sixth People's Hospital

zhoujian@sjtu.edu.cn+86 18930172033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026